These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7585731)

  • 21. [Blood levels of dehydroepiandrosterone sulfate (DHEA-S) and the risk of breast cancer].
    Gomes P; Cassanas G; Halberg F; Hermida R; Robel P; Baulieu EE; Lakatua D; Haus E
    C R Acad Sci III; 1988; 306(7):261-4. PubMed ID: 2967730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of breast cyst subpopulations: biochemical and morphological features.
    Zanardi S; Valenti G; Torrisi R; Maisto L; Nicolò G; Barreca A; Minuto F; Boccardo F
    Cancer Detect Prev; 1991; 15(4):273-6. PubMed ID: 1838953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The protein of fibrocystic breast disease--methods of measurement and clinical implications].
    Lefebvre J
    Bull Acad Natl Med; 1997 Oct; 181(7):1487-500; discussion 1500-1. PubMed ID: 9528190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.
    Miller WR; Humeniuk V; Forrest AP
    Breast Cancer Res Treat; 1981; 1(3):267-72. PubMed ID: 6216932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active androgens in breast cyst fluids.
    Suarez B; Vizoso F; Allende MT; Fernández Fernández M; Fdez Llana B; Roiz MC; Ruibal A
    Int J Biol Markers; 1992; 7(4):263-4. PubMed ID: 1491184
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development.
    Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J
    Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of epidermal growth factor in human breast cyst fluids: correlation with dehydroepiandrosterone-sulphate and electrolyte concentrations.
    Smith K; Miller WR; Fennelly JA; Matthews JN; Scott WN; Harris AL
    Int J Cancer; 1989 Aug; 44(2):229-32. PubMed ID: 2527206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cyst fluid plasmin activity and its effect on TGF-beta2 activation.
    Erbas H; Erten O; Irfanoglu ME
    Cancer Invest; 2008 Feb; 26(1):22-7. PubMed ID: 18181041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemistry of breast cyst fluid: correlation with breast cancer risk.
    Ann N Y Acad Sci; 1990; 586():1-294. PubMed ID: 2356992
    [No Abstract]   [Full Text] [Related]  

  • 32. Melatonin and estrogen in breast cyst fluids.
    Burch JB; Walling M; Rush A; Hennesey M; Craven W; Finlayson C; Anderson BO; Cosma G; Wells RL
    Breast Cancer Res Treat; 2007 Jul; 103(3):331-41. PubMed ID: 17061046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammary cysts: pathophysiology and biochemistry.
    Angeli A; Dogliotti L; Orlandi F; Beccati D
    Int J Rad Appl Instrum B; 1987; 14(4):397-406. PubMed ID: 2958434
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women.
    Elsadig RE; Reimann K; Yip CH; Lai LC
    Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro metabolism or testosterone by breast microcysts.
    Lai LC; James VH
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):613-5. PubMed ID: 2278847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of the sulfates of 16 alpha-hydroxy androgens that are possible precursors of estriol-3-sulfate in human breast cyst fluid.
    Raju U; Levitz M; Jacobowitz G; Fleisher M; Bencsath FA; Field FH; Breed CN; Naganuma H; Bradlow HL
    Steroids; 1987; 50(4-6):559-74. PubMed ID: 2974194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease.
    Boccuzzi G; Brignardello E; Massobrio M; Bonino L
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1099-102. PubMed ID: 2958288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between levels of dehydroepiandrosterone-sulphate and prolactin in human breast cyst fluid.
    Angeli A; Boccuzzi G; Agrimonti F; Brignardello E; Barbadoro E; Dogliotti L
    Tumori; 1982 Oct; 68(5):393-6. PubMed ID: 6217610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.